リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Fulminant myocarditis with myositis of ocular and respiratory muscles」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Fulminant myocarditis with myositis of ocular and respiratory muscles

Hiraiwa, Hiroaki Furusawa, Kenji Kazama, Shingo Kimura, Yuki Shibata, Naoki Arao, Yoshihito Oishi, Hideo Kato, Hiroo Kuwayama, Tasuku Yamaguchi, Shogo Kondo, Toru Sawamura, Akinori Morimoto, Ryota Okumura, Takahiro Murohara, Toyoaki 名古屋大学

2020.08

概要

A 46-year-old Japanese woman visited a nearby hospital because of diplopia after flu-like symptoms. One month later, she presented with blepharoptosis and external ophthalmoplegia. Laboratory tests showed a high creatine kinase concentration (3146 U/L). She underwent intravenous immunoglobulin therapy; however, her symptoms did not improve, prompting transfer to our institute. On admission, transthoracic echocardiography revealed 30% of left ventricular ejection fraction and edema of the left ventricular wall. Coronary angiography showed no significant coronary stenosis. An endomyocardial biopsy resulted in a diagnosis of acute myocarditis. On the following day, she needed a temporary pacemaker because she had complete atrioventricular block and intra-aortic balloon pump because of cardiogenic shock. Intravenous immunoglobulin therapy was again administered and her cardiac function gradually recovered. She was successfully weaned off her temporary pacemaker and intra-aortic balloon pump on Day 5 after improvement in her complete atrioventricular block. Steroid therapy administered from Day 9 was effective in reducing her creatine kinase concentrations. However, contrast-enhanced magnetic resonance imaging revealed inflammation of the scalene, semispinalis cervicis, sternocleidomastoid, and intercostal muscles. On Day 25, her cardiac function had recovered to a left ventricular ejection fraction of 59%. Finally, she was successfully discharged on Day 45 after undergoing rehabilitation.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working

Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–2648, 48a–48d. doi: 10.1093/

eurheartj/eht210.

2. Sharma AN, Stultz JR, Bellamkonda N, Amsterdam EA. Fulminant myocarditis: epidemiology, pathogenesis,

diagnosis, and management. Am J Cardiol. 2019;S0002–9149(19)31055-0. doi: 10.1016/j.amjcard.2019.09.017.

3. Ammirati E, Veronese G, Brambatti M, et al. Fulminant versus acute nonfulminant myocarditis in

patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019;74(3):299–311. doi: 10.1016/j.

jacc.2019.04.063.

4. Sawamura A, Okumura T, Hirakawa A, et al. Early prediction model for successful bridge to recovery

in patients with fulminant myocarditis supported with percutaneous venoarterial extracorporeal membrane

oxygenation: insights from the CHANGE PUMP Study. Circ J. 2018;82(3):699–707. doi: 10.1253/circj.

CJ-17-0549.

5. Sawamura A, Okumura T, Ito M, et al. Prognostic value of electrocardiography in patients with fulminant

myocarditis supported by percutaneous venoarterial extracorporeal membrane oxygenation: analysis from

the CHANGE PUMP Study. Circ J. 2018;82(8):2089–2095. doi: 10.1253/circj.CJ-18-0136.

6. Sagar S, Liu PP, Cooper LT. Myocarditis. Lancet. 2012;379(9817):738–747. doi: 10.1016/S01406736(11)60648-X.

7. Nauss MD, Schmidt EL, Pancioli AM. Viral myositis leading to rhabdomyolysis: a case report and literature

review. Am J Emerg Med. 2009;27(3):372.e5–72.e6. doi: 10.1016/j.ajem.2008.07.022.

8. Sato H, Iwasaki E, Nogawa S, et al. A patient with giant cell myocarditis and myositis associated with

thymoma and myasthenia gravis [in Japanese]. Rinsho Shinkeigaku. 2003;43(8):496–499.

9. Suzuki S, Utsugisawa K, Yoshikawa H, et al. Autoimmune targets of heart and skeletal muscles in

myasthenia gravis. Arch Neurol. 2009;66(11):1334–1338. doi: 10.1001/archneurol.2009.229.

10. Suzuki S, Satoh T, Yasuoka H, et al. Novel autoantibodies to a voltage-gated potassium channel Kv1.4

in a severe form of myasthenia gravis. J Neuroimmunol. 2005;170(1–2):141–149. doi: 10.1016/j.jneuroim.2005.08.017.

11. Suzuki S, Utsugisawa K, Nagane Y, Suzuki N. Three types of striational antibodies in myasthenia gravis.

Autoimmune Dis. 2011;2011:740583. doi: 10.4061/2011/740583.

12. Shimizu J. Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies

[in Japanese]. Rinsho Shinkeigaku. 2013;53(11):1114–1116. doi: 10.5692/clinicalneurol.53.1114.

13. Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies.

Brain. 2012;135(Pt 6):1767–1777. doi: 10.1093/brain/aws106.

14. Johnson DB, Balko JM, Compton ML, et al. Fulminant myocarditis with combination immune checkpoint

blockade. N Engl J Med. 2016;375(18):1749–1755. doi: 10.1056/NEJMoa1609214.

15. Varricchi G, Galdiero MR, Marone G, et al. Cardiotoxicity of immune checkpoint inhibitors. ESMO Open.

2017;2(4):e000247. doi: 10.1136/esmoopen-2017-000247.

593

Myocarditis with atypical myositis

16. Touat M, Maisonobe T, Knauss S, et al. Immune checkpoint inhibitor-related myositis and myocarditis in

patients with cancer. Neurology. 2018;91(10):e985–e994. doi: 10.1212/WNL.0000000000006124.

17. JCS Joint Working Group. Guidelines for Diagnosis and Treatment of Myocarditis (JCS 2009).

18. Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain

reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll

Cardiol. 2003;42(3):466–472. doi: 10.1016/s0735-1097(03)00648-x.

19. Maisch B, Bauer E, Cirsi M et al. Cytolytic cross-reactive antibodies directed against the cardiac membrane

and viral proteins in coxsackievirus B3 and B4 myocarditis: characterization and pathogenetic relevance.

Circulation. 1993;87(5)(Suppl):IV49–65.

20. Kaya Z, Katus HA, Rose NR. Cardiac troponins and autoimmunity: their role in the pathogenesis of

myocarditis and of heart failure. Clin Immunol. 2010;134(1):80–88. doi: 10.1016/j.clim.2009.04.008.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る